Chemokine-enhanced DNA vaccination in cancer immunotherapy

    loading  Checking for direct PDF access through Ovid


We have demonstrated that priming of intratumoral and intradermal vaccination sites with chemokines enhances cytotoxic immune response against established neoplasms. Additional insights into the molecular mechanisms that underlie these findings and the optimization of such an approach may lead to the development of cost-effective and generic immunotherapeutic regimens against cancer.

Related Topics

    loading  Loading Related Articles